0001437749-17-006118.txt : 20170405
0001437749-17-006118.hdr.sgml : 20170405
20170405130922
ACCESSION NUMBER: 0001437749-17-006118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aviragen Therapeutics, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
BUSINESS PHONE: 301-770-3099
MAIL ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20020304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLONNESE MARK P
CENTRAL INDEX KEY: 0001040766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 17741851
MAIL ADDRESS:
STREET 1: 8995 WESTSIDE PARKWAY
CITY: ALPHARETTA
STATE: GA
ZIP: 30004
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-04-03
0000072444
Aviragen Therapeutics, Inc.
AVIR
0001040766
COLONNESE MARK P
2500 NORTHWINDS PARKWAY
STE 100
ALPHARETTA
GA
30009
1
Chief Financial Officer
Stock Option (Right to Buy)
0.656
2017-04-03
4
A
0
400000
0.656
A
2017-10-03
2027-04-03
Common Stock
400000
775000
D
This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018.
/s/ Mark P Colonnese
2017-04-05